Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC. Reply

N Engl J Med. 2024 Jan 25;390(4):381-382. doi: 10.1056/NEJMc2314327.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Humans
  • Proto-Oncogene Proteins c-ret
  • Pyrazoles*
  • Pyridines

Substances

  • pembrolizumab
  • selpercatinib
  • Antibodies, Monoclonal, Humanized
  • Pyrazoles
  • Pyridines
  • RET protein, human
  • Proto-Oncogene Proteins c-ret